Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Renal Function With Enfortumab Vedotin in Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study in Japan

YUKI KOBARI, JUNPEI IIZUKA, HANAE KONDO, MAKIKO ICHIOKA, SHUN WATANABE, KAZUTAKA NAKAMURA, YUKI NEMOTO, TOSHIHIDE HORIUCHI, SHINSUKE MIZOGUCHI, KAZUHIKO YOSHIDA, HIROAKI SHIMMURA, YASUNOBU HASHIMOTO, TSUNENORI KONDO, HIROSHI KOBAYASHI and TOSHIO TAKAGI
Anticancer Research December 2025, 45 (12) 5645-5654; DOI: https://doi.org/10.21873/anticanres.17898
YUKI KOBARI
1Department of Urology, Tokyo Women’s Medical University Hospital, Tokyo, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: yuukikobari17{at}gmail.com
JUNPEI IIZUKA
1Department of Urology, Tokyo Women’s Medical University Hospital, Tokyo, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HANAE KONDO
2Department of Urology, Saiseikai Kawaguchi General Hospital, Kawaguchi, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MAKIKO ICHIOKA
1Department of Urology, Tokyo Women’s Medical University Hospital, Tokyo, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SHUN WATANABE
1Department of Urology, Tokyo Women’s Medical University Hospital, Tokyo, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KAZUTAKA NAKAMURA
1Department of Urology, Tokyo Women’s Medical University Hospital, Tokyo, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YUKI NEMOTO
3Department of Urology, Joban Hospital, Fukushima, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TOSHIHIDE HORIUCHI
4Department of Urology, Tokyo Women’s Medical University, Adachi Medical Center, Adachi, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SHINSUKE MIZOGUCHI
5Department of Urology, Saiseikai Kazo Hospital, Kazo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KAZUHIKO YOSHIDA
1Department of Urology, Tokyo Women’s Medical University Hospital, Tokyo, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HIROAKI SHIMMURA
3Department of Urology, Joban Hospital, Fukushima, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YASUNOBU HASHIMOTO
2Department of Urology, Saiseikai Kawaguchi General Hospital, Kawaguchi, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TSUNENORI KONDO
4Department of Urology, Tokyo Women’s Medical University, Adachi Medical Center, Adachi, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HIROSHI KOBAYASHI
5Department of Urology, Saiseikai Kazo Hospital, Kazo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TOSHIO TAKAGI
1Department of Urology, Tokyo Women’s Medical University Hospital, Tokyo, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.

patientACCESS

patientACCESS - Patients desiring access to articles
PreviousNext
Back to top

In this issue

Anticancer Research: 45 (12)
Anticancer Research
Vol. 45, Issue 12
December 2025
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Ed Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Renal Function With Enfortumab Vedotin in Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study in Japan
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
3 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Renal Function With Enfortumab Vedotin in Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study in Japan
YUKI KOBARI, JUNPEI IIZUKA, HANAE KONDO, MAKIKO ICHIOKA, SHUN WATANABE, KAZUTAKA NAKAMURA, YUKI NEMOTO, TOSHIHIDE HORIUCHI, SHINSUKE MIZOGUCHI, KAZUHIKO YOSHIDA, HIROAKI SHIMMURA, YASUNOBU HASHIMOTO, TSUNENORI KONDO, HIROSHI KOBAYASHI, TOSHIO TAKAGI
Anticancer Research Dec 2025, 45 (12) 5645-5654; DOI: 10.21873/anticanres.17898

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Renal Function With Enfortumab Vedotin in Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study in Japan
YUKI KOBARI, JUNPEI IIZUKA, HANAE KONDO, MAKIKO ICHIOKA, SHUN WATANABE, KAZUTAKA NAKAMURA, YUKI NEMOTO, TOSHIHIDE HORIUCHI, SHINSUKE MIZOGUCHI, KAZUHIKO YOSHIDA, HIROAKI SHIMMURA, YASUNOBU HASHIMOTO, TSUNENORI KONDO, HIROSHI KOBAYASHI, TOSHIO TAKAGI
Anticancer Research Dec 2025, 45 (12) 5645-5654; DOI: 10.21873/anticanres.17898
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Patients and Methods
    • Results
    • Discussion
    • Conclusion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Prognostic Impact of Early GNRI Sustainability in Metastatic Urothelial Carcinoma Receiving Pembrolizumab
  • Delayed Initiation of Postoperative S-1 Adjuvant Chemotherapy Worsens Prognosis After Gastric Cancer Recurrence
  • Clinical Outcomes of the Optimized Weekly 8-Gy Palliative Radiotherapy Regimen
Show more Clinical Studies

Keywords

  • enfortumab vedotin
  • chronic kidney disease
  • Urothelial carcinoma
  • renal function
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire